Calcification and cellularity in human aortic heart valve tissue determine the differentiation of bone-marrow-derived cells

Journal of Molecular and Cellular Cardiology

Volumn 41, Issue 4, 2006, Pages 642-649

  Leskelä, Hannu Ville ^a   Satta, Jari ^a   Oiva, Jani ^a   Eriksen, Heidi ^a   Juha, Risteli ^a   Korkiamäki, Paula ^a   Ivaska, Kaisa K ^b   Soini, Ylermi ^a   Lehenkari, Petri ^a  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Aortic valves; Co culture; Differentiation; Mesenchymal stem cells; Osteogenesis

Indexed keywords

OSTEOCALCIN; PROCOLLAGEN; PROCOLLAGEN TYPE 1; UNCLASSIFIED DRUG;

AORTA VALVE DISEASE; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CALCIFICATION; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME ACTIVITY; EVALUATION; EXPLANT; FREEZE THAWING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INJURY; MESENCHYMAL STEM CELL; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AORTIC VALVE; BIOLOGICAL MARKERS; BONE MARROW CELLS; CALCINOSIS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MESENCHYMAL STEM CELLS; MODELS, BIOLOGICAL; OSTEOBLASTS; OSTEOGENESIS; PEPTIDE ELONGATION FACTOR 1;

EID: 33748573243     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.07.014     Document Type: Article

References (27)

1. Kaden J.J., Bickelhaupt S., Grobholz R., Haase K.K., Sarikoc A., Kilic R., et al. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification. J. Mol. Cell. Cardiol. 36 (2004) 57-66
2. O'Brien K.D., Kuusisto J., Reichenbach D.D., Ferguson M., Giachelli C., Alpersee C.E., et al. Osteopontin is expressed in human aortic valvular lesions. Circulation 92 (1995) 2163-2168
3. Rajamannan N.M., Subramaniam M., Rickard D., Stock S.R., Donovan J., Springett M., et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 107 (2003) 2181-2184
4. Mohler III E.R., Chawla M.K., Chang A.W., Vyavahare N., Levy R.J., Graham L., et al. Identification and characterization of calcifying valve cells from human and canine aortic valves. J. Heart Valve Dis. 8 (1999) 254-260
5. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276 (1997) 71-74
6. Eghbali-Fatourechi G.Z., Lamsam J., Fraser D., Nagel D., Riggs B.L., and Khosla S. Circulating osteoblast-lineage cells in humans. N. Engl. J. Med. 352 (2005) 1959-1966
7. Kuznetsov S.A., Mankani M.H., Gronthos S., Satomura K., Bianco P., and Robey P.G. Circulating skeletal stem cells. J. Cell Biol. 153 (2001) 1133-1140
8. Giachelli C.M. Ectopic calcification: gathering hard facts about soft tissue mineralization. Am. J. Pathol. 154 (1999) 671-675
9. Soini Y., Salo T., and Satta J. Angiogenesis is involved in the pathogenesis of nonrheumatic aortic valve stenosis. Hum. Pathol. 34 (2003) 756-763
10. Deb A., Wang S.H., Skelding K., Miller D., Simper D., and Caplice N. Bone marrow-derived myofibroblasts are present in adult human heart valves. J. Heart Valve Dis. 14 (2005) 674-678
11. Leskela H.V., Risteli J., Niskanen S., Koivunen J., Ivaska K.K., and Lehenkari P. Osteoblast recruitment from stem cells does not decrease by age at late adulthood. Biochem. Biophys. Res. Commun. 311 (2003) 1008-1013
12. Kakonen S.M., Hellman J., Karp M., Laaksonen P., Obrant K.J., Vaananen H.K., et al. Development and evaluation of three immunofluorometric assays that measure different forms of osteocalcin in serum. Clin. Chem. 46 (2000) 332-337
13. Hellman J., Kakonen S.M., Matikainen M.T., Karp M., Lovgren T., Vaananen H.K., et al. Epitope mapping of nine monoclonal antibodies against osteocalcin: combinations into two-site assays affect both assay specificity and sample stability. J. Bone Miner. Res. 11 (1996) 1165-1175
14. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
15. Bittira B., Kuang J.Q., Al-Khaldi A., Shum-Tim D., and Chiu R.C. In vitro preprogramming of marrow stromal cells for myocardial regeneration. Ann. Thorac. Surg. 74 (2002) 1154-1159
16. Spees J.L., Olson S.D., Ylostalo J., Lynch P.J., Smith J., Perry A., et al. Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 2397-2402
17. Wu X., Huang L., Zhou Q., Song Y., Li A., Jin J., et al. Mesenchymal stem cells participating in ex vivo endothelium repair and its effect on vascular smooth muscle cells growth. Int. J. Cardiol. 105 (2005) 274-282
18. Hauschka P.V., Lian J.B., Cole D.E., and Gundberg C.M. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol. Rev. 69 (1989) 990-1047
19. Ghazvini-Boroujerdi M., Clark J., Narula N., Palmatory E., Connolly J.M., DeFelice S., et al. Transcription factor Egr-1 in calcific aortic valve disease. J. Heart Valve Dis. 13 (2004) 894-903
20. Ball S.G., Shuttleworth A.C., and Kielty C.M. Direct cell contact influences bone marrow mesenchymal stem cell fate. Int. J. Biochem. Cell Biol. 36 (2004) 714-727
21. Karsenty G. The complexities of skeletal biology. Nature 423 (2003) 316-318
22. Hosoya A., Hoshi K., Sahara N., Ninomiya T., Akahane S., Kawamoto T., et al. Effects of fixation and decalcification on the immunohistochemical localization of bone matrix proteins in fresh-frozen bone sections. Histochem. Cell Biol. 123 (2005) 639-646
23. Cowell S.J., Newby D.E., Prescott R.J., Bloomfield P., Reid J., Northridge D.B., et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N. Engl. J. Med. 352 (2005) 2389-2397
24. Rosenhek R., Rader F., Loho N., Gabriel H., Heger M., Klaar U., et al. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation 110 (2004) 1291-1295
25. Wu B., Elmariah S., Kaplan F.S., Cheng G., and Mohler III E.R. Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts: implications for end-stage valvular heart disease. Arterioscler., Thromb., Vasc. Biol. 25 (2005) 592-597
26. Mundy G., Garrett R., Harris S., Chan J., Chen D., Rossini G., et al. Stimulation of bone formation in vitro and in rodents by statins. Science 286 (1999) 1946-1949
27. Salo T., Soini Y., Oiva J., Ylitalo K., Nissinen A., Biancari F., Juvonen T., and Satta J. Chemically modified tetracyclines (CMT-3 and CMT-8) enable control of the pathologic remodellation of human aortic valve stenosis via MMP-9 and VEGF inhibition. Int J Cardiol (2005) (Oct. 17)